515 related articles for article (PubMed ID: 16351634)
1. Platelet transfusion prophylaxis for patients with haematological malignancies: where to now?
Stanworth SJ; Hyde C; Brunskill S; Murphy MF
Br J Haematol; 2005 Dec; 131(5):588-95. PubMed ID: 16351634
[TBL] [Abstract][Full Text] [Related]
2. Platelet transfusions for patients with haematological malignancies: who needs them?
Estcourt LJ; Stanworth SJ; Murphy MF
Br J Haematol; 2011 Aug; 154(4):425-40. PubMed ID: 21615375
[TBL] [Abstract][Full Text] [Related]
3. Compliance with prophylactic platelet transfusion trigger in haematological patients.
Eikenboom JC; van Wordragen R; Brand A
Transfus Med; 2005 Feb; 15(1):45-8. PubMed ID: 15713128
[TBL] [Abstract][Full Text] [Related]
4. Current practice and future directions for optimization of platelet transfusions in patients with severe therapy-induced cytopenia.
Apelseth TO; Hervig T; Bruserud O
Blood Rev; 2011 May; 25(3):113-22. PubMed ID: 21316823
[TBL] [Abstract][Full Text] [Related]
5. Thrombocytopenia and platelet transfusions in patients with cancer.
Valent J; Schiffer CA
Cancer Treat Res; 2011; 157():251-65. PubMed ID: 21052961
[TBL] [Abstract][Full Text] [Related]
6. Platelet utilization and the transfusion trigger: a prospective analysis.
Greeno E; McCullough J; Weisdorf D
Transfusion; 2007 Feb; 47(2):201-5. PubMed ID: 17302764
[TBL] [Abstract][Full Text] [Related]
7. Background, rationale, and design of a clinical trial to assess the effects of platelet dose on bleeding risk in thrombocytopenic patients.
Slichter SJ
J Clin Apher; 2006 Apr; 21(1):78-84. PubMed ID: 16619231
[TBL] [Abstract][Full Text] [Related]
8. An audit of platelet transfusion within the Wellington Cancer Centre.
Buhrkuhl DC; Karlsson MK; Carter JM
Intern Med J; 2012 Jan; 42(1):65-70. PubMed ID: 21040321
[TBL] [Abstract][Full Text] [Related]
9. New strategies for the optimal use of platelet transfusions.
Blajchman MA; Slichter SJ; Heddle NM; Murphy MF
Hematology Am Soc Hematol Educ Program; 2008; ():198-204. PubMed ID: 19074082
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic platelet transfusion versus routine prophylactic transfusion in patients with haematological malignancies: an open-label, multicentre, randomised study.
Wandt H; Schaefer-Eckart K; Wendelin K; Pilz B; Wilhelm M; Thalheimer M; Mahlknecht U; Ho A; Schaich M; Kramer M; Kaufmann M; Leimer L; Schwerdtfeger R; Conradi R; Dölken G; Klenner A; Hänel M; Herbst R; Junghanss C; Ehninger G;
Lancet; 2012 Oct; 380(9850):1309-16. PubMed ID: 22877506
[TBL] [Abstract][Full Text] [Related]
11. Prophylactic platelet transfusions: should they be a treatment of the past?
Zeller MP; Al-Habsi KS; Heddle NM
Curr Opin Hematol; 2014 Nov; 21(6):521-7. PubMed ID: 25203535
[TBL] [Abstract][Full Text] [Related]
12. The platelet prophylactic transfusion trigger: when expectations meet reality.
Brecher ME
Transfusion; 2007 Feb; 47(2):188-91. PubMed ID: 17302761
[No Abstract] [Full Text] [Related]
13. Do all patients with hematologic malignancies and severe thrombocytopenia need prophylactic platelet transfusions? Background, rationale, and design of a clinical trial (trial of platelet prophylaxis) to assess the effectiveness of prophylactic platelet transfusions.
Stanworth SJ; Dyer C; Choo L; Bakrania L; Copplestone A; Llewelyn C; Norfolk D; Powter G; Littlewood T; Wood EM; Murphy MF;
Transfus Med Rev; 2010 Jul; 24(3):163-71. PubMed ID: 20656185
[TBL] [Abstract][Full Text] [Related]
14. Prophylactic platelet transfusion for haemorrhage after chemotherapy and stem cell transplantation.
Stanworth SJ; Hyde C; Heddle N; Rebulla P; Brunskill S; Murphy MF
Cochrane Database Syst Rev; 2004 Oct; (4):CD004269. PubMed ID: 15495093
[TBL] [Abstract][Full Text] [Related]
15. Hypoplastic thrombocytopenia and platelet transfusion: therapeutic goals.
Karakatsanis SJ; Papadatos SS; Syrigos KN
Hosp Pract (1995); 2019 Feb; 47(1):16-23. PubMed ID: 30409035
[TBL] [Abstract][Full Text] [Related]
16. Very high users of platelet transfusions in the neonatal intensive care unit.
Dohner ML; Wiedmeier SE; Stoddard RA; Null D; Lambert DK; Burnett J; Baer VL; Hunt JC; Henry E; Christensen RD
Transfusion; 2009 May; 49(5):869-72. PubMed ID: 19175546
[TBL] [Abstract][Full Text] [Related]
17. [Transfusion of platelet concentrates].
Rieux C; Lee K; Lavaud A; Bierling P
Ann Med Interne (Paris); 1999 Dec; 150(8):631-41. PubMed ID: 10686645
[TBL] [Abstract][Full Text] [Related]
18. Utilization of platelet transfusions in the intensive care unit: indications, transfusion triggers, and platelet count responses.
Arnold DM; Crowther MA; Cook RJ; Sigouin C; Heddle NM; Molnar L; Cook DJ
Transfusion; 2006 Aug; 46(8):1286-91. PubMed ID: 16934061
[TBL] [Abstract][Full Text] [Related]
19. Optimizing platelet transfusion therapy.
Heal JM; Blumberg N
Blood Rev; 2004 Sep; 18(3):149-65. PubMed ID: 15183900
[TBL] [Abstract][Full Text] [Related]
20. A therapeutic platelet transfusion strategy is safe and feasible in patients after autologous peripheral blood stem cell transplantation.
Wandt H; Schaefer-Eckart K; Frank M; Birkmann J; Wilhelm M
Bone Marrow Transplant; 2006 Feb; 37(4):387-92. PubMed ID: 16400342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]